Free Trial

LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular logo
$79.91 -10.33 (-11.45%)
As of 01:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LMAT vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, TMDX, PRCT, and NVST

Should you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

LeMaitre Vascular vs.

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 0.9%. Stevanato Group pays out 12.5% of its earnings in the form of a dividend. LeMaitre Vascular pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has increased its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

LeMaitre Vascular received 484 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%
LeMaitre VascularOutperform Votes
515
70.45%
Underperform Votes
216
29.55%

84.6% of LeMaitre Vascular shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 10.8% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. Stevanato Group is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.10B5.69$157.62M$0.4843.21
LeMaitre Vascular$219.86M9.27$30.10M$1.9446.52

LeMaitre Vascular has a consensus target price of $98.14, indicating a potential upside of 8.76%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
LeMaitre Vascular
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.63

In the previous week, LeMaitre Vascular had 13 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for LeMaitre Vascular and 4 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.35 beat LeMaitre Vascular's score of 0.49 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LeMaitre Vascular
6 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Stevanato Group has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

LeMaitre Vascular has a net margin of 19.40% compared to Stevanato Group's net margin of 10.47%. LeMaitre Vascular's return on equity of 13.15% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
LeMaitre Vascular 19.40%13.15%11.47%

Summary

LeMaitre Vascular beats Stevanato Group on 15 of the 21 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LMAT vs. The Competition

MetricLeMaitre VascularSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.04B$4.33B$5.54B$7.93B
Dividend Yield0.87%39.93%5.09%4.23%
P/E Ratio49.3130.0322.5818.55
Price / Sales9.2755.31401.13103.29
Price / Cash56.5251.0838.1834.62
Price / Book6.746.056.774.25
Net Income$30.10M$68.71M$3.22B$248.18M
7 Day Performance-1.50%-0.24%1.10%0.91%
1 Month Performance4.18%-2.90%2.49%2.59%
1 Year Performance35.15%21.00%15.76%4.02%

LeMaitre Vascular Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LMAT
LeMaitre Vascular
2.7507 of 5 stars
$79.91
-11.4%
$98.14
+22.8%
+35.1%$1.80B$219.86M43.57490Earnings Report
News Coverage
Gap Down
STVN
Stevanato Group
1.1556 of 5 stars
€21.65
-1.0%
N/A-26.5%$6.56B$1.10B46.064,650Positive News
GKOS
Glaukos
4.7544 of 5 stars
$88.17
-2.3%
$156.17
+77.1%
-15.8%$4.99B$383.48M-30.72780Earnings Report
Analyst Forecast
News Coverage
NARI
Inari Medical
0.306 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800News Coverage
INSP
Inspire Medical Systems
4.8529 of 5 stars
$144.74
-3.6%
$218.90
+51.2%
-35.2%$4.31B$802.80M83.67760Upcoming Earnings
Positive News
BLCO
Bausch + Lomb
3.8245 of 5 stars
$12.05
-0.1%
$18.82
+56.2%
-15.6%$4.26B$4.79B-13.2412,500Earnings Report
Analyst Forecast
News Coverage
SLNO
Soleno Therapeutics
4.6541 of 5 stars
$68.93
-1.5%
$99.63
+44.5%
+57.8%$3.16BN/A-20.7630Upcoming Earnings
News Coverage
Positive News
IRTC
iRhythm Technologies
0.8597 of 5 stars
$98.63
-2.3%
$119.73
+21.4%
-2.8%$3.10B$591.84M-27.101,790Earnings Report
Analyst Forecast
News Coverage
Gap Up
TMDX
TransMedics Group
3.2097 of 5 stars
$87.72
-0.6%
$122.70
+39.9%
-23.1%$2.97B$441.54M93.32210Analyst Forecast
PRCT
PROCEPT BioRobotics
2.6981 of 5 stars
$53.43
+0.8%
$91.43
+71.1%
-12.8%$2.93B$224.50M-27.40430Analyst Revision
Gap Up
High Trading Volume
NVST
Envista
3.6531 of 5 stars
$14.88
-2.0%
$19.96
+34.2%
-17.1%$2.56B$2.51B-2.2912,700Earnings Report
Analyst Forecast
News Coverage

Related Companies and Tools


This page (NASDAQ:LMAT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners